133 related articles for article (PubMed ID: 8905344)
1. Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells.
Lee K; Ibbotson T; Richardson PJ; Boden PR
Eur J Pharmacol; 1996 Oct; 313(1-2):163-7. PubMed ID: 8905344
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone inhibits type 2KATP channel activity and depolarises tolbutamide-sensitive neurones in the rat ventromedial hypothalamus.
Lee K; Boden P
Brain Res; 1997 Mar; 751(1):165-8. PubMed ID: 9098583
[TBL] [Abstract][Full Text] [Related]
3. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
Harvey J; Ashford ML
Br J Pharmacol; 1998 Aug; 124(7):1557-65. PubMed ID: 9723971
[TBL] [Abstract][Full Text] [Related]
4. Effect of englitazone on KATP and calcium-activated non-selective cation channels in CRI-G1 insulin-secreting cells.
Rowe IC; Lee K; Khan RN; Ashford ML
Br J Pharmacol; 1997 Jun; 121(3):531-9. PubMed ID: 9179397
[TBL] [Abstract][Full Text] [Related]
5. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
[TBL] [Abstract][Full Text] [Related]
6. Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells.
Harvey J; Ashford ML
J Physiol; 1998 Sep; 511 ( Pt 3)(Pt 3):695-706. PubMed ID: 9714853
[TBL] [Abstract][Full Text] [Related]
7. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1.
Harvey J; McKenna F; Herson PS; Spanswick D; Ashford ML
J Physiol; 1997 Nov; 504 ( Pt 3)(Pt 3):527-35. PubMed ID: 9401961
[TBL] [Abstract][Full Text] [Related]
8. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK.
Deng R; Nie A; Jian F; Liu Y; Tang H; Zhang J; Zhang Y; Shao L; Li F; Zhou L; Wang X; Ning G
Biochim Biophys Acta; 2014 Jan; 1840(1):577-85. PubMed ID: 24144566
[TBL] [Abstract][Full Text] [Related]
9. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
Lee K; Ozanne SE; Hales CN; Ashford ML
Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
[TBL] [Abstract][Full Text] [Related]
10. Dual actions of the metabolic inhibitor, sodium azide on K(ATP) channel currents in the rat CRI-G1 insulinoma cell line.
Harvey J; Hardy SC; Ashford ML
Br J Pharmacol; 1999 Jan; 126(1):51-60. PubMed ID: 10051120
[TBL] [Abstract][Full Text] [Related]
11. Glitazones exert multiple effects on β-cell stimulus-secretion coupling.
Düfer M; Noack K; Edalat A; Krippeit-Drews P; Drews G
Mol Pharmacol; 2013 Jan; 83(1):51-60. PubMed ID: 23024191
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes.
Knock GA; Mishra SK; Aaronson PI
Eur J Pharmacol; 1999 Feb; 368(1):103-9. PubMed ID: 10096775
[TBL] [Abstract][Full Text] [Related]
13. Effects of chemical modification of amino and sulfhydryl groups on KATP channel function and sulfonylurea binding in CRI-G1 insulin-secreting cells.
Lee K; Ozanne SE; Hales CN; Ashford ML
J Membr Biol; 1994 May; 139(3):167-81. PubMed ID: 7745597
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig.
Katoh Y; Hashimoto S; Kimura J; Watanabe T
Jpn J Pharmacol; 2000 Feb; 82(2):102-9. PubMed ID: 10877527
[TBL] [Abstract][Full Text] [Related]
15. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
Lee K; Ozanne SE; Rowe IC; Hales CN; Ashford ML
Mol Pharmacol; 1994 Jul; 46(1):176-85. PubMed ID: 8058051
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells.
Ohtani KI; Shimizu H; Sato N; Mori M
Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412
[TBL] [Abstract][Full Text] [Related]
18. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes.
Mishra SK; Aaronson PI
Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats.
Shimabukuro M; Zhou YT; Lee Y; Unger RH
J Biol Chem; 1998 Feb; 273(6):3547-50. PubMed ID: 9452481
[TBL] [Abstract][Full Text] [Related]
20. Enhanced inhibition of L-type calcium currents by troglitazone in streptozotocin-induced diabetic rat cardiac ventricular myocytes.
Arikawa M; Takahashi N; Kira T; Hara M; Saikawa T; Sakata T
Br J Pharmacol; 2002 Jul; 136(6):803-10. PubMed ID: 12110604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
